HEADER TRANSFERASE 08-OCT-13 4N49 TITLE CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-METHYLTRANSFERASE 1 PROTEIN IN TITLE 2 COMPLEX WITH M7GPPPG AND SAM COMPND MOL_ID: 1; COMPND 2 MOLECULE: CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-METHYLTRANSFERASE 1; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: CAP1 2'O-RIBOSE METHYLTRANSFERASE 1, MTR1, HMTR1, FTSJ COMPND 5 METHYLTRANSFERASE DOMAIN-CONTAINING PROTEIN 2, INTERFERON-STIMULATED COMPND 6 GENE 95 KDA PROTEIN, ISG95; COMPND 7 EC: 2.1.1.57; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: FTSJD2, KIAA0082, MTR1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS METHYLTRANSFERASE, MRNA CAP METHYLATION, MRNA, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR M.SMIETANSKI,M.WERENER,E.PURTA,K.H.KAMINSKA,J.STEPINSKI, AUTHOR 2 E.DARZYNKIEWICZ,M.NOWOTNY,J.M.BUJNICKI REVDAT 3 20-SEP-23 4N49 1 REMARK SEQADV REVDAT 2 15-NOV-17 4N49 1 REMARK REVDAT 1 22-JAN-14 4N49 0 JRNL AUTH M.SMIETANSKI,M.WERNER,E.PURTA,K.H.KAMINSKA,J.STEPINSKI, JRNL AUTH 2 E.DARZYNKIEWICZ,M.NOWOTNY,J.M.BUJNICKI JRNL TITL STRUCTURAL ANALYSIS OF HUMAN 2'-O-RIBOSE METHYLTRANSFERASES JRNL TITL 2 INVOLVED IN MRNA CAP STRUCTURE FORMATION. JRNL REF NAT COMMUN V. 5 3004 2014 JRNL REFN ESSN 2041-1723 JRNL PMID 24402442 JRNL DOI 10.1038/NCOMMS4004 REMARK 2 REMARK 2 RESOLUTION. 1.90 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE: 1.8.2_1309) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.90 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 46.80 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 2.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 3 NUMBER OF REFLECTIONS : 36369 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.156 REMARK 3 R VALUE (WORKING SET) : 0.154 REMARK 3 FREE R VALUE : 0.203 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1818 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 46.8438 - 4.4665 1.00 2713 141 0.1303 0.1644 REMARK 3 2 4.4665 - 3.5456 1.00 2687 142 0.1186 0.1610 REMARK 3 3 3.5456 - 3.0975 1.00 2678 141 0.1399 0.1890 REMARK 3 4 3.0975 - 2.8143 1.00 2641 139 0.1523 0.2076 REMARK 3 5 2.8143 - 2.6126 1.00 2671 140 0.1540 0.1911 REMARK 3 6 2.6126 - 2.4586 1.00 2664 141 0.1485 0.2323 REMARK 3 7 2.4586 - 2.3355 1.00 2662 140 0.1508 0.2050 REMARK 3 8 2.3355 - 2.2338 0.99 2632 138 0.1677 0.2114 REMARK 3 9 2.2338 - 2.1478 1.00 2649 140 0.1712 0.2082 REMARK 3 10 2.1478 - 2.0737 1.00 2642 139 0.1776 0.2345 REMARK 3 11 2.0737 - 2.0089 1.00 2657 140 0.1955 0.2835 REMARK 3 12 2.0089 - 1.9514 1.00 2645 139 0.2158 0.2622 REMARK 3 13 1.9514 - 1.9001 0.99 2610 138 0.2634 0.3050 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.220 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 19.850 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.012 3428 REMARK 3 ANGLE : 1.302 4662 REMARK 3 CHIRALITY : 0.089 500 REMARK 3 PLANARITY : 0.005 602 REMARK 3 DIHEDRAL : 14.542 1279 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4N49 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 25-NOV-13. REMARK 100 THE DEPOSITION ID IS D_1000082732. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 22-FEB-11 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : BESSY REMARK 200 BEAMLINE : 14.1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.918410 REMARK 200 MONOCHROMATOR : SI-111 CRYSTAL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 225 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XDS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 36369 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.900 REMARK 200 RESOLUTION RANGE LOW (A) : 46.800 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.100 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 4N4A REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 48.81 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.40 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 30% PEG 3350, 100 MM BIS-TRIS [PH REMARK 280 6.5], AND 100 MM NABR, VAPOR DIFFUSION, TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 43.80950 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 123 REMARK 465 ALA A 124 REMARK 465 MET A 125 REMARK 465 ARG A 126 REMARK 465 GLY A 127 REMARK 465 LEU A 128 REMARK 465 GLY A 129 REMARK 465 LEU A 130 REMARK 465 THR A 131 REMARK 465 LEU A 132 REMARK 465 ARG A 133 REMARK 465 GLY A 134 REMARK 465 PHE A 135 REMARK 465 ASP A 136 REMARK 465 GLN A 137 REMARK 465 GLU A 138 REMARK 465 LEU A 139 REMARK 465 ASN A 140 REMARK 465 ALA A 316 REMARK 465 SER A 317 REMARK 465 SER A 318 REMARK 465 GLU A 319 REMARK 465 LEU A 320 REMARK 465 ALA A 548 REMARK 465 PRO A 549 REMARK 465 SER A 550 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 148 CG CD OE1 OE2 REMARK 470 GLU A 160 CG CD OE1 OE2 REMARK 470 LYS A 264 CE NZ REMARK 470 LYS A 309 CE NZ REMARK 470 GLU A 425 CD OE1 OE2 REMARK 470 GLU A 530 CG CD OE1 OE2 REMARK 470 LYS A 533 CE NZ REMARK 470 VAL A 547 CG1 CG2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 NZ LYS A 179 OD2 ASP A 474 2.14 REMARK 500 O GLY A 326 O HOH A 1107 2.15 REMARK 500 O HOH A 821 O HOH A 843 2.16 REMARK 500 OG1 THR A 163 O HOH A 1099 2.17 REMARK 500 O HOH A 1053 O HOH A 1215 2.17 REMARK 500 O HOH A 851 O HOH A 1203 2.19 REMARK 500 O HOH A 973 O HOH A 974 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 CYS A 428 CA - CB - SG ANGL. DEV. = 6.8 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 MET A 182 55.40 -93.51 REMARK 500 CYS A 191 135.91 -172.27 REMARK 500 ARG A 228 -129.80 47.83 REMARK 500 VAL A 230 -115.52 50.44 REMARK 500 PHE A 247 35.40 -99.04 REMARK 500 LYS A 292 -42.05 73.78 REMARK 500 GLN A 372 40.81 -141.97 REMARK 500 PHE A 406 -133.78 -105.55 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 CYS A 277 ALA A 278 -147.45 REMARK 500 REMARK 500 REMARK: NULL REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 MGT A 602 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SAM A 601 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MGT A 602 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NA A 603 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4N48 RELATED DB: PDB REMARK 900 SAME PROTEIN IN COMPLEX WITH SHORTER RNA REMARK 900 RELATED ID: 4N4A RELATED DB: PDB DBREF 4N49 A 126 550 UNP Q8N1G2 MTR1_HUMAN 126 550 SEQADV 4N49 GLY A 123 UNP Q8N1G2 EXPRESSION TAG SEQADV 4N49 ALA A 124 UNP Q8N1G2 EXPRESSION TAG SEQADV 4N49 MET A 125 UNP Q8N1G2 EXPRESSION TAG SEQRES 1 A 428 GLY ALA MET ARG GLY LEU GLY LEU THR LEU ARG GLY PHE SEQRES 2 A 428 ASP GLN GLU LEU ASN VAL ASP TRP ARG ASP GLU PRO GLU SEQRES 3 A 428 PRO SER ALA CYS GLU GLN VAL SER TRP PHE PRO GLU CYS SEQRES 4 A 428 THR THR GLU ILE PRO ASP THR GLN GLU MET SER ASP TRP SEQRES 5 A 428 MET VAL VAL GLY LYS ARG LYS MET ILE ILE GLU ASP GLU SEQRES 6 A 428 THR GLU PHE CYS GLY GLU GLU LEU LEU HIS SER VAL LEU SEQRES 7 A 428 GLN CYS LYS SER VAL PHE ASP VAL LEU ASP GLY GLU GLU SEQRES 8 A 428 MET ARG ARG ALA ARG THR ARG ALA ASN PRO TYR GLU MET SEQRES 9 A 428 ILE ARG GLY VAL PHE PHE LEU ASN ARG ALA ALA MET LYS SEQRES 10 A 428 MET ALA ASN MET ASP PHE VAL PHE ASP ARG MET PHE THR SEQRES 11 A 428 ASN PRO ARG ASP SER TYR GLY LYS PRO LEU VAL LYS ASP SEQRES 12 A 428 ARG GLU ALA GLU LEU LEU TYR PHE ALA ASP VAL CYS ALA SEQRES 13 A 428 GLY PRO GLY GLY PHE SER GLU TYR VAL LEU TRP ARG LYS SEQRES 14 A 428 LYS TRP HIS ALA LYS GLY PHE GLY MET THR LEU LYS GLY SEQRES 15 A 428 PRO ASN ASP PHE LYS LEU GLU ASP PHE TYR SER ALA SER SEQRES 16 A 428 SER GLU LEU PHE GLU PRO TYR TYR GLY GLU GLY GLY ILE SEQRES 17 A 428 ASP GLY ASP GLY ASP ILE THR ARG PRO GLU ASN ILE SER SEQRES 18 A 428 ALA PHE ARG ASN PHE VAL LEU ASP ASN THR ASP ARG LYS SEQRES 19 A 428 GLY VAL HIS PHE LEU MET ALA ASP GLY GLY PHE SER VAL SEQRES 20 A 428 GLU GLY GLN GLU ASN LEU GLN GLU ILE LEU SER LYS GLN SEQRES 21 A 428 LEU LEU LEU CYS GLN PHE LEU MET ALA LEU SER ILE VAL SEQRES 22 A 428 ARG THR GLY GLY HIS PHE ILE CYS LYS THR PHE ASP LEU SEQRES 23 A 428 PHE THR PRO PHE SER VAL GLY LEU VAL TYR LEU LEU TYR SEQRES 24 A 428 CYS CYS PHE GLU ARG VAL CYS LEU PHE LYS PRO ILE THR SEQRES 25 A 428 SER ARG PRO ALA ASN SER GLU ARG TYR VAL VAL CYS LYS SEQRES 26 A 428 GLY LEU LYS VAL GLY ILE ASP ASP VAL ARG ASP TYR LEU SEQRES 27 A 428 PHE ALA VAL ASN ILE LYS LEU ASN GLN LEU ARG ASN THR SEQRES 28 A 428 ASP SER ASP VAL ASN LEU VAL VAL PRO LEU GLU VAL ILE SEQRES 29 A 428 LYS GLY ASP HIS GLU PHE THR ASP TYR MET ILE ARG SER SEQRES 30 A 428 ASN GLU SER HIS CYS SER LEU GLN ILE LYS ALA LEU ALA SEQRES 31 A 428 LYS ILE HIS ALA PHE VAL GLN ASP THR THR LEU SER GLU SEQRES 32 A 428 PRO ARG GLN ALA GLU ILE ARG LYS GLU CYS LEU ARG LEU SEQRES 33 A 428 TRP GLY ILE PRO ASP GLN ALA ARG VAL ALA PRO SER HET SAM A 601 27 HET MGT A 602 32 HET NA A 603 1 HETNAM SAM S-ADENOSYLMETHIONINE HETNAM MGT 7N-METHYL-8-HYDROGUANOSINE-5'-TRIPHOSPHATE HETNAM NA SODIUM ION FORMUL 2 SAM C15 H22 N6 O5 S FORMUL 3 MGT C11 H20 N5 O14 P3 FORMUL 4 NA NA 1+ FORMUL 5 HOH *542(H2 O) HELIX 1 1 GLY A 192 VAL A 205 1 14 HELIX 2 2 PHE A 206 LEU A 209 5 4 HELIX 3 3 ASP A 210 ASN A 222 1 13 HELIX 4 4 TYR A 224 ARG A 228 5 5 HELIX 5 5 ASN A 234 PHE A 247 1 14 HELIX 6 6 LYS A 264 ALA A 268 5 5 HELIX 7 7 GLY A 281 LYS A 292 1 12 HELIX 8 8 LYS A 309 PHE A 313 5 5 HELIX 9 9 ARG A 338 ASN A 352 1 15 HELIX 10 10 GLN A 372 ASN A 374 5 3 HELIX 11 11 LEU A 375 SER A 380 1 6 HELIX 12 12 SER A 380 ILE A 394 1 15 HELIX 13 13 THR A 410 CYS A 423 1 14 HELIX 14 14 ILE A 453 ARG A 471 1 19 HELIX 15 15 PRO A 482 GLY A 488 1 7 HELIX 16 16 ASP A 489 ASP A 520 1 32 HELIX 17 17 ARG A 527 GLY A 540 1 14 SHEET 1 A 2 VAL A 176 LYS A 179 0 SHEET 2 A 2 SER A 475 LEU A 479 -1 O ASP A 476 N GLY A 178 SHEET 1 B 7 GLU A 322 PRO A 323 0 SHEET 2 B 7 ALA A 295 MET A 300 1 N GLY A 297 O GLU A 322 SHEET 3 B 7 LEU A 271 VAL A 276 1 N LEU A 271 O LYS A 296 SHEET 4 B 7 VAL A 358 ALA A 363 1 O HIS A 359 N TYR A 272 SHEET 5 B 7 VAL A 395 THR A 405 1 O ARG A 396 N VAL A 358 SHEET 6 B 7 ARG A 442 LEU A 449 -1 O CYS A 446 N PHE A 401 SHEET 7 B 7 PHE A 424 PHE A 430 -1 N ARG A 426 O LYS A 447 LINK NA NA A 603 O HOH A1035 1555 1555 3.00 CISPEP 1 GLY A 279 PRO A 280 0 3.37 SITE 1 AC1 22 ASN A 234 ALA A 236 CYS A 277 ALA A 278 SITE 2 AC1 22 GLY A 279 PRO A 280 GLY A 281 GLY A 282 SITE 3 AC1 22 PHE A 283 THR A 301 LEU A 302 ASN A 306 SITE 4 AC1 22 GLY A 334 ASP A 335 ILE A 336 ASP A 364 SITE 5 AC1 22 GLY A 366 LEU A 383 HOH A 758 HOH A 887 SITE 6 AC1 22 HOH A1103 HOH A1174 SITE 1 AC2 20 LYS A 203 SER A 204 PHE A 206 ASP A 207 SITE 2 AC2 20 MET A 214 ARG A 218 GLU A 373 ASN A 374 SITE 3 AC2 20 ALA A 438 ASN A 439 HOH A 759 HOH A 822 SITE 4 AC2 20 HOH A 865 HOH A 878 HOH A 928 HOH A 954 SITE 5 AC2 20 HOH A 955 HOH A1035 HOH A1076 HOH A1101 SITE 1 AC3 6 ARG A 235 LYS A 239 ARG A 436 ASN A 439 SITE 2 AC3 6 GLU A 441 HOH A1035 CRYST1 50.834 87.619 57.310 90.00 112.89 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.019672 0.000000 0.008307 0.00000 SCALE2 0.000000 0.011413 0.000000 0.00000 SCALE3 0.000000 0.000000 0.018941 0.00000